Miss Monika Kaushik

Breast Health

Enquiries & Appointments

Make an Enquiry

Profile Summary

Qualifications

MBBS, DNB, MRCS, MD, FRCS

Special Interests

Nipple and areolar surgery, Oncoplastic breast surgery, Breast cancer, Breast lumps, Breast Pain, Nipple discharge, Breast reconstruction, Risk reducing breast surgery, Revision breast surgery, Breast augmentation, Breast reduction

Recognised by

Make an Enquiry
Image of Miss Monika Kaushik

Video Consultations

Please call or make an enquiry to book

Group 12 Created with Sketch.

Specialist Treatments

Treatments offered at King Edward VII's Hospital include, but are not limited to:

  • Mastectomy
  • Core Biopsy
  • Breast Reconstruction Surgery
  • Breast Augmentation Surgery
  • Mastopexy
  • Breast Reduction Surgery
  • Lumpectomy
  • Nipple Reconstruction Surgery

My Practice

Miss Kaushik is a highly experienced breast surgeon known for her holistic, multidisciplinary approach and commitment to evidence-based practice.

Professional Biography

Miss Monika Kaushik is a highly esteemed and experienced consultant oncoplastic and breast surgeon at King Edward VII's Hospital. Miss Kaushik specialises in breast cancer diagnosis and treatment, cosmetic breast surgery, breast reconstruction and corrective surgery as well as various benign breast-related conditions, but to mention a few. {{ label }}

She currently practices privately at various hospitals in Leicestershire, Nottinghamshire, and in London at King Edward VII’s Hospital. She is also working at the University Hospitals of Leicester NHS Trust since her appointment as consultant oncoplastic and breast surgeon in 2013.

Miss Kaushik’s main areas of clinical interests are: modern management of breast cancer; having a holistic approach. She has obtained a substantial amount of experience in relation to various breast-related surgical procedures, including skin and nipple sparing mastectomies, therapeutic mammoplasties, breast augmentation, breast reduction, nipple reconstruction, risk-reducing breast surgery, as well as sentinel lymph node biopsy to name a few.

Miss Kaushik actively and willingly engages herself in various medical research trials, on both a national and local level, with her main areas of research interest being axiliary treatment in breast cancer, breast cancer predictive and prognostic markers, neoadjuvant therapy in breast cancer, as well as seeking to improve surgical outcomes in oncoplastic breast surgery.

She also holds various roles in education and management, and is also a member of the Advisory Committee of Spire Nottingham Hospital. She is certified and registered by Royal College of Surgeons to practice breast cosmetic surgery
Additional Information

COVID-19 Specific Projects / Groups

Ms Kaushik completed a study which she presented at a National Conference – ‘The Effects of the COVID-19 pandemic on Breast Cancer Services at a tertiary University Hospital’

Career Highlights

Miss Kaushik states her biggest success is the compliments and positive feedback from my patients. In addition, she hold various Educational and Senior Management Posts including Research Lead.

Awards

Nominated for ‘Outstanding Contribution in Clinical Practice Award’ in the NHS, July 2024

Memberships

Board member for the Medical Advisory Committee at Spire Nottingham Hospital

Royal College of Surgeons

Association of Breast Surgeons

Training Positions

Miss Kaushik trains consultants who have returned after a long period of leave. She also trained and supervised Consultants for Perforator flaps and Pre-pectoral implant reconstruction

Cutting Edge Technologies

She  has had a large number of patient cohort who have had a pre-pectoral reconstruction with good outcomes. Accomplished in reconstruction using a perforator flap (which can help reduce chances of a mastectomy)

Publications

  • An optimised patient derived explant platform for breast cancer refects clinical responses to chemotherapy and antibody directed therapy
    http://www.nature.com/scientificreports. (2024) 14:12833
  • ‘PartBreCon’ study. A UK multicentre retrospective cohort study to assess outcomes following PARTial BREast reCONstruction with chest wall perforator flaps
    The Breast: Volume 71, October 2023, Pages 82-88
  • Axillary sentinel lymph node identification using supermagnetic iron oxide versus radioisotope in early stage breast cancer: The UK SentiMag trial ( SMART study)
    The Surgeon 21 ( 2023), Issue 2 p128-134
  • The MARECA (national study of management of breast cancer locoregional recurrence and oncological outcomes) study: National practice questionnaire of United Kingdom multi-disciplinary decision making
    European Journal of Surgical OncologyVol. 48Issue 7p1510–1519Published online: April 4, 2022
  • Bridging pre-surgical endocrine therapy for breast cancer during the COVID-19 pandemic: outcomes from the B-MaP-C study
    Breast Cancer Res Treat . 2023 Jun;199(2):265-279. doi: 10.1007/s10549-023-06893-4. Epub 2023 Apr 3
  • External Validation of a Predictive Model for Acute Skin Radiation Toxicity in the REQUITE Breast Cohort ( Collaborator)
    Front Oncol . 2020 Oct 30;10:575909. doi: 10.3389/fonc.2020.575909. eCollection 2020.
  • REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer (Collaborator)
    Radiother Oncol
    . 2019 Sep;138:59-67. doi: 10.1016/j.radonc.2019.04.034. Epub 2019 May 27
  • The impact of immediate breast reconstruction on the time to delivery of adjuvant therapy: the iBRA-2 study ( Collaborator)
    Br J Cancer . 2019 Apr;120(9):883-895. doi: 10.1038/s41416-019-0438-1. Epub 2019 Mar 29
  • Development of a method for generating SNP interaction-aware polygenic risk scores for radiotherapy toxicity ( Collaborator)
    Radiother Oncol . 2021 Jun;159:241-248. doi: 10.1016/j.radonc.2021.03.024. Epub 2021 Apr 8
  • Therapeutic mammaplasty is a safe and effective alternative to mastectomy with or without immediate breast reconstruction ( Collaborator)
    Br J Surg . 2020 Jun;107(7):832-844. doi: 10.1002/bjs.11468. Epub 2020 Feb 19
  • Multicentre prospective observational study evaluating recommendations for mastectomy by multidisciplinary teams
    Mastectomy Decisions Audit (MasDA) Collaborative, on behalf of the West Midlands Research Collaborative ( Collaborator)
    Br J Surg . 2020 Feb;107(3):227-237. doi: 10.1002/bjs.11383. Epub 2019 Nov 5
  • Axillary sentinel lymph node identification using superparamagnetic iron oxide versus radioisotope in early stage breast cancer : The UK SentiMag trial ( SMART study)
    The Surgeon, Volume 21, Issue 2, April 2023, 128-134
  • Identification Using Superparamagnetic Iron Oxide Versus Radioisotope in Early Stage Breast Cancer: The UK SentiMag Trial (SMART Study) . Cureus (): e. doi:10.7759/cureus.
  • A Prospective, single – arm, multicenter clinical evaluation of a new localization technique using non’radioactive magseeds for surgery of clinically occult breast lesions
    Clin Radiol 2019 Dec;74(12):974.e7-974.e11
  • S. Puri, N. Sharma, R.G. Newcombe, M. Kaushik, M. Al-Attar,
    S. Pascaline, M. Hajaj, M.G. Wallis, B. Elsberger, A. Goyal
    Axillary tumour burden in women with one abnormal node on ultrasound compared to
    women with multiple abnormal nodes
    Clinical Radiology (2017), https://doi.org/10.1016/j.crad.2017.12.014
  • Oliveira-Cunha M, S Shokuhi, Kaushik M
    Male Breast Cancer – Single centre experience and current evidence
    The Breast Journal 2014: 20(6)674

Need some help?
Call 020 7467 4344

Our team is available to take your call Mon - Fri - 8am – 6pm

Request a call back

{{ successMessage }}
Sorry something went wrong, please check the below errors and try again.

Sometimes it’s easier for us to call you.
Leave your name, number and a little information about what you’d like to discuss, and we’ll be in touch.

{{ hasErrors('name') }}
{{ hasErrors('phone') }}
{{ hasErrors('message') }}